Evidence map›Paper›PMID 25052587›Full record

Trial reportRadiation oncology (London, England)2014

Weight and body mass index in relation to irradiated volume and to overall survival in patients with oropharyngeal cancer: a retrospective cohort study.

Sandra Ottosson, Karin Söderström, Elisabeth Kjellén, Per Nilsson, Björn Zackrisson, Göran Laurell

Registry-linked trialAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Radiation oncology (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06860425 (Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity), which is not on this map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06860425 narecruitingnot on this mapstarted 2023, after this paper: background citation

Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity

TypeinterventionalSponsorMontefiore Medical CenterRan2023 to 2027Enrolled50ConditionsMobile Applications, Cancer PatientsArmsRestoreMe
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The impact of dietary regimen compliance on outcomes for HNSCC patients treated with radiation therapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Obesity in patients with carcinoma cervix increases the risk of adverse events.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
    Article
  18. Commentary.Indian journal of palliative care
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sandra OttossonDepartment of Clinical Sciences, Otorhinolaryngology, Umeå University, Umeå, Sweden. sandra.ottosson@kost.umu.se.
Karin Söderström
Elisabeth Kjellén
Per Nilsson
Björn Zackrisson
Göran Laurell

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWeight loss is a common problem in patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN) treated with radiotherapy (RT). The aims of the present study were to determine if treated volume (TV), as a measure of the radiation dose burden, can predict weight loss in patients with oropharyngeal cancer and to analyze weight loss and body mass index (BMI) in the same patient group in relation to 5-year overall survival.

methodsThe ARTSCAN trial is a prospective, randomized, multicenter trial in patients with SCCHN. Nutritional data from the ARTSCAN trial were analyzed retrospectively using univariate and multivariate statistical methods based on information on percentage weight loss from the start of RT up to five months after the termination of RT (study cohort 1, n = 232) and information on patients' BMI at the start of RT (study cohort 2, n = 203). TV was defined as the volume of the patient receiving at least 95% of the prescribed dose. TV64.6 Gy encompasses macroscopic tumor and TV43.7 Gy elective lymph nodes of the neck.

resultsTV64.6 Gy and TV43.7 Gy were both significantly correlated with higher weight loss up to five months after the termination of RT in study cohort 1 (p < 0.001 for both). BMI at the start of RT was shown to be a prognostic factor for 5-year overall survival in study cohort 2 but weight loss was not. The hazard ratios and 95% confidence intervals were 3.78 (1.46-9.75) and 2.57 (1.43-4.62) in patients with underweight and normal weight, respectively.

conclusionsTV can predict weight loss during RT in patients with oropharyngeal cancer regardless of clinical stage. A high BMI (>25 kg/m2) at the start of RT is positively associated with survival in patients with oropharyngeal cancer.

Indexed as

Body Mass IndexAdultAgedAged, 80 and overBody WeightCarcinoma, Squamous CellFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm StagingObesityOropharyngeal NeoplasmsPrognosisProspective Studies

Identifiers

PMID25052587
PMCPMC4112828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.